Supporting this notion, recent multi-omics data of patient samples showed that unlike LUAD 25, KEAP1 mutations did not result in significantly reduced protein expression in LUSC, suggesting the differences in NRF2 pathway dysregulation between NSCLC subtypes 26. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.